| Value | ₹25.00 Cr |
|---|
BSE filing, NSE: IDEAFORGE. Summary written from the filing by ALFA Finder's alert engine.
ideaForge Technology Ltd: key numbers
- Share price
- ₹714.15
- Market cap
- ₹3,551 Cr
- Revenue (annual)
- ₹226.1 Cr
- Net profit (annual)
- ₹-17.03 Cr
- P/E (TTM)
- 118.3×Sector 51.9×
- Promoter holding
- 25.25%-3.71% QoQ
- FII holding
- 7.27%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from ideaForge Technology Ltd
All →ideaForge Technology Earnings Call Transcript: Key Takeaways
Ideaforge returned to profitability with Q2 revenue up 124% YoY, executing 50% of its FY27 opening order book.
ideaForge Technology Investor Presentation: Key Takeaways
Q2 FY27 revenue INR 912.9 Mn (+124% YoY), PAT INR 64.6 Mn (7.1% margin), EBITDA 25.4%, a turnaround from loss. Defence is 72% of revenue.
ideaForge Technology Results Update
ideaForge reported Q2 FY27 revenue of ₹91.3 crore and PAT of ₹6.5 crore, turning profitable. H1 revenue reached a record ₹159.9 crore.
ideaForge Technology Q2 FY27 Results: Turns Profitable, Net Profit ₹6.5 Cr
ideaForge Technology Ltd reported revenue from operations of ₹91.3 Cr (+123.8% YoY) and net profit of ₹6.5 Cr for Q2 FY27.
- Key figure
- Net profit ₹6.5 Cr
ideaForge Technology Merger & Restructuring
ideaForge's US subsidiary terminated its JV agreement with First Breach Inc. on October 23, 2026. Closing never occurred, so no shares were issued or capital contributed.
ideaForge Technology Board Meeting Date
IdeaForge Technology scheduled a Board meeting for November 2, 2026, to approve Q2 and H1 unaudited results. Trading window remains closed until 48 hours post-declaration.
Other other announcement announcements
All →Neueon Corporation Other Announcement
Neueon Corporation's members approved amendments to its Articles of Association via postal ballot, now approved by the Registrar of Companies. The amendment allows the Board to make multiple calls on partly paid shares.
Balaxi Pharmaceuticals Other Announcement
Balaxi Pharmaceuticals filed its RTA report for October 2026 on re-lodgement of physical share transfers. All request counts for the month are NIL.
Leapfrog Engineering Services Other Announcement
Leapfrog Engineering received a Trade Mark registration certificate for building construction services in Class 37. The registration discloses no monetary value or business impact.
Quest Laboratories Other Announcement
Quest Laboratories reported no deviation in IPO fund utilisation for the half year ended September 2026. Its statement was reviewed by the Audit Committee.
Vinyas Innovative Technologies Other Announcement
Vinyas Innovative filed CRISIL's monitoring agency report for the quarter ended 30 September 2026. It reports no deviation from objects for its preferential warrant issue proceeds.
Parag Milk Foods Other Announcement
Sixth Sense India Opportunities III sold 43,842 shares on NSE for about Rs 1.45 Crore. Its stake fell from 1.44% to 1.40%.
- Value
- ₹1.45 Cr